Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Re: MNTA’s cash balance and operating-expense guidance

The cash balance at 6/30/15 was $397.9M (including $20.7M of restricted cash):

http://finance.yahoo.com/news/momenta-pharmaceuticals-reports-second-quarter-120000157.html

During 2Q15, MNTA generated approximately $197M of cash from financing transactions:

• $148M from May 2015 pubic offering @$19/sh (including underwriter’s option)
• $31M from the old and new ATM facilities
• $18 from option exercises by employees

For 3Q15 and 4Q15, MNTA expects to have net operating expenses excluding Glatopa revenue of $36-40M per quarter.